Estos frmacos han demostrado no solo ser efectivos en la reduccin del peso corporal, sino que tambin han mostrado beneficios adicionales sobre diversas enfermedades asociadas a la obesidad que afectan de manera muy prevalente a las personas que conviven con obesidad (fig
Glucagon-like peptide-1 (GLP-1) receptor agonists, originally developed for type 2 diabetes management, have emerged as a promising treatment for weight loss, with secondary benefits for OSA
it's creating visible, measurable changes that contribute to a smoother, more youthful-looking complexion
In the early stages of breakdown, the solution can look perfectly normal while delivering significantly reduced potency
While some patients may experience mild side effects, these are typically minimal and short-lived
Furthermore, as demonstrated by the findings of the TUNEL analysis, GHK administration resulted in a notable decrease in apoptotic cells, suggesting that neuronal death was inhibited, accelerating neurological recovery [173]